Skip to main content

Find Clinical Trials

Home
Conditions
Bone Marrow Diseases

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 528 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

NCT00534469

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Not specified

View Trial Details

Completed

Severe Immune Cytopenia Registry Www.Sic-reg.Org

NCT03576742

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +31 more
Locations: Pediatric Hematology-Oncology Outpatient Clinic Graz, Styria, Austria

View Trial Details

Completed

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

NCT01139970

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +45 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States

Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

NCT03011372

Conditions: Bone Marrow Diseases, Eosinophilia, Hematologic Diseases, +4 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

Stanford Cancer Institute Stanford, California, United States

Emory University - Winship Cancer Institute Atlanta, Georgia, United States

View all 33 locations

View Trial Details

Completed

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

NCT02996773

Conditions: Actinomycetales Infections, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +52 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant

NCT02684162

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

NCT01760655

Conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, +61 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

NCT03268954

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +13 more
Locations: Southern Cancer Center - USOR Daphne, Alabama, United States

Southern Cancer Center - USOR Mobile, Alabama, United States

Southern Cancer Center - USOR Mobile, Alabama, United States

Southern Cancer Center- USOR Mobile, Alabama, United States

View all 242 locations

View Trial Details

Completed

Resiliency in Older Adults Undergoing Bone Marrow Transplant

NCT04188678

Conditions: Acute Myelogenous Leukemia, Blood Cancer, Bone Marrow Diseases, +18 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation

NCT04666259

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations: Alaska Oncology and Hematology Anchorage, Alaska, United States

Arizona Oncology Associates Phoenix, Arizona, United States

Cancer Treatment Centers of America Phoenix, Arizona, United States

Pacific Shores Medical Group Long Beach, California, United States

View all 26 locations

View Trial Details